Immunological basis of virus-host interaction in COVID-19.


Journal

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718

Informations de publication

Date de publication:
11 2020
Historique:
received: 27 07 2020
accepted: 04 08 2020
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 15 12 2020
Statut: ppublish

Résumé

COVID-19 is a complex new viral disease, in which a strict balance between anti-viral immune response and the ensuing organ inflammation has a critical role in determining the clinical course. In adults, compelling evidence exists indicating that an uncontrolled inflammatory response ("cytokine storm") is pivotal in determining disease progression and mortality. Children may rarely present with severe disease. Modulating factors related to the host's genetic factors, age-related susceptibility, and the capability to mount appropriate immune responses might play a role in control virus load at an early stage and regulating the inflammatory reaction. Elucidating these mechanisms seems crucial in developing target therapies according to patient's age, immunologic status, and disease evolution in COVID-19.

Identifiants

pubmed: 33236427
doi: 10.1111/pai.13363
pmc: PMC7753582
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-78

Informations de copyright

© 2020 European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Références

Lancet Child Adolesc Health. 2020 Jun;4(6):414-416
pubmed: 32458804
Arthritis Rheumatol. 2020 Jul;72(7):1059-1063
pubmed: 32293098
Pediatr Allergy Immunol. 2020 Jul;31(5):565-569
pubmed: 32319118
Pediatr Allergy Immunol. 2020 Nov;31 Suppl 26:75-78
pubmed: 33236427
J Allergy Clin Immunol. 2020 Jul;146(1):211-213.e4
pubmed: 32333914
J Infect Dis. 2005 Oct 15;192(8):1355-61
pubmed: 16170752
Clin Immunol. 2020 Jun;215:108448
pubmed: 32353634
Lancet. 2020 Jun 6;395(10239):1771-1778
pubmed: 32410760
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Pediatr Allergy Immunol. 2020 Jul;31(5):449-453
pubmed: 32330332
JAMA Pediatr. 2020 Sep 1;174(9):882-889
pubmed: 32320004

Auteurs

Francesco La Torre (F)

Department of Pediatrics, Giovanni XXIII Pediatric Hospital, Bari, Italy.

Lucia Leonardi (L)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Giuliana Giardino (G)

Pediatric Section, Department of Translational Medical Sciences, Federico II University, Naples, Italy.

Stefano Volpi (S)

Center for Autoinflammatory Diseases and Immunodeficiency, IRCCS Istituto Giannina Gaslini, Università degli Studi di Genova, Genoa, Italy.

Silvia Federici (S)

Division of Rheumatology, IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy.

Annarosa Soresina (A)

Pediatrics Clinic, ASST-Spedali Civili of Brescia, Brescia, Italy.

Caterina Cancrini (C)

Academic Department of Pediatrics, Immune and Infectious Diseases Division, Research Unit of Primary Immunodeficiencies, Bambino Gesu` Children's Hospital, IRCCS, Rome, Italy.

Vassilios Lougaris (V)

Department of Clinical and Experimental Sciences, Pediatrics Clinic and Institute for Molecular Medicine A. Nocivelli, University of Brescia and ASST-Spedali Civili di Brescia, Brescia, Italy.

Riccardo Castagnoli (R)

Department of Pediatrics, Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.

Stefania Corrente (S)

Pediatrics Department, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.

Fabio Cardinale (F)

Department of Pediatrics, Giovanni XXIII Pediatric Hospital, Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH